Global Softgel Capsule Market Size, Share, and COVID-19 Impact Analysis, By Type (Gelatin Capsules and Non-Gelatin Softgel Capsules), By Manufacturers (Pharmaceutical Companies, Nutraceutical Companies, and Others), By Application (Health Supplements, Pharmaceuticals, and Cosmetics & Personal Care), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
Industry: HealthcareGlobal Softgel Capsule Market Insights Forecasts to 2033
- The Global Softgel Capsule Market Size was Valued at USD 1.25 Billion in 2023
- The Market Size is Growing at a CAGR of 6.29% from 2023 to 2033
- The Worldwide Softgel Capsule Market Size is Expected to Reach USD 2.30 Billion by 2033
- Asia Pacific is Expected to Grow the fastest during the forecast period.
Get more details on this report -
The Global Softgel Capsule Market Size is Anticipated to Exceed USD 2.30 Billion by 2033, Growing at a CAGR of 6.29% from 2023 to 2033.
Market Overview
Soft gel capsules also referred to as soft elastic capsules, are powdered or liquid medicine capsules made of gelatin that dissolve more quickly than hard gelatin capsules. It is a part of various medications and dietary supplements, including omega-3 fish oils. Better atmospheric stability, improved absorption, increased availability, and effective flavor and odor masking are just a few advantages of soft gel capsules. Because of improvements in manufacturing technology and the advent of new materials, traditional capsules have evolved to offer more benefits such as tamper-evident features, controlled release of the medication, and more alternatives for stronger API formulations. These developments have made it feasible to create a wider range of medicinal formulations, which have improved appearance, longer shelf lives, and less pH degradation. Soft gelatin capsules are utilized in the pharmaceutical business for a variety of purposes, including antacids, health supplements, treatments for bacterial infections, and medications for cardiovascular illnesses. Because of its many advantages over traditional oral solid dose forms, soft gel capsules are becoming more and more popular as a dosage form. Dosage forms for soft gel capsules were created to cover up the disagreeable taste and smell of prescription drugs. Taken with water, soft gel capsules are easier to swallow than tablets. The pandemic caused a notable increase in sales for the soft gel capsule market. The development of capsules for strong and essential drug molecules to overcome bioavailability issues, the development of capsules for medications requiring multiple excipients, such as cancer medicines, and patient preference for capsules over other oral dosage forms are additional factors driving the market's growth. Because of the outbreak, sales of soft gel capsules increased significantly.The market is expanding due to various factors like patient preference for capsules over other oral dosage forms, the development of capsules for strong and essential drug molecules to overcome bioavailability issues, and the development of capsules for medications requiring multiple excipients, such as cancer medicines.
Report Coverage
This research report categorizes the market for the global softgel capsule market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global softgel capsule market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global softgel capsule market.
Global Softgel Capsule Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023 : | USD 1.25 Billion |
Forecast Period: | 2023 – 2033 |
Forecast Period CAGR 2023 – 2033 : | 6.29% |
023 – 2033 Value Projection: | USD 2.30 Billion |
Historical Data for: | 2019-2022 |
No. of Pages: | 250 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Type, By Manufacturers, By Application, By Region |
Companies covered:: | Sirio Pharma Company Limited., Catalent, Inc., EuroCaps Ltd., Guangdong Yichao Biological Co., Ltd., Aenova Group., CAPTEK Softgel International Inc., Thermo Fisher Scientific Inc., EyePoint Pharmaceuticals, Inc., Windzor Pharma Ltd., Lonza Capsules & Health Ingredients., ProCaps Laboratories, LLC., Soft Gel Technologies, Inc., Elnova Pharma., Captek Softgel International Inc., Hunan Er-Kang Pharmaceutical Co., Ltd, and Others key vendors |
Pitfalls & Challenges: | Covid-19 Impact, Challenge, Future,Growth and Analysis |
Get more details on this report -
Driving Factors
One useful and efficient application for soft gel capsules is the delivery of both liquid and solid drugs. Its versatility allows it to be encapsulated with a wide range of ingredients, including oils, prescription drugs, vitamins, and minerals. Softgel capsules are also believed to have a higher bioavailability than traditional tablet forms, which implies that the active ingredients will be absorbed by the body more effectively. Sensitive substances are shielded from oxygen and moisture by the airtight barrier of soft gel capsules, increasing their potency and shelf life. Softgel capsules have become the most often used delivery method because they enhance the body's absorption of oil-based nutrients. Because of their easily digested soft and gelatinous outer shell, soft gels are perfect for stimulating components such as flaxseed, algae, salmon, and krill oils. Nutraceutical manufacturers are constantly innovating and creating new product formulas using soft gels to meet the growing demand. As a result, soft gel capsule usage has increased significantly.
Restraining Factors
The impact of softgel capsule production on the environment is a growing concern for both regulators and consumers. The production of gelatin may result in waste products, and the use of solvents and other chemicals harm the environment. The conventional process of making gelatin involves liming, which is time-consuming and highly polluting to the environment.
Market Segmentation
The global softgel capsule market share is classified into type, manufactures, and application.
- The gelatin softgel capsules segment dominates the market with the largest market share through the forecast period.
Based on the type, the global softgel capsule market is categorized into gelatin softgel capsules and non-gelatin softgel capsules. Among these, the gelatin softgel capsules segment dominates the market with the largest market share through the forecast period. Due to the fact that gelatin offers so many advantages over substitutes, it continues to be the ingredient of choice for manufacturers. Its remarkable qualities, including its inert and clean-label nature, ease of digestion, effective tamper-evident capsule production, superior mechanical resistance, high-quality seals, patient compliance, and abundant availability as a resource, have greatly contributed to its market growth.
- The pharmaceutical companies segment is anticipated to grow at the fastest CAGR growth through the forecast period.
Based on the manufactures, the global softgel capsule market is categorized into pharmaceutical companies, nutraceutical companies, and others. Among these, the pharmaceutical companies segment is anticipated to grow at the fastest CAGR growth through the forecast period. Pharmaceutical companies have significantly increased their manufacture of softgel capsules, because pharmaceutical businesses have substantial R&D activities and production capability.
- The health supplements segment accounted for the largest revenue share through the forecast period.
Based on the application, the global softgel capsule market is categorized into health supplements, pharmaceuticals, and cosmetics & personal care. Among these, the health supplements segment accounted for the largest revenue share through the forecast period. This is related to a rise in the use of softgel capsules as health supplements containing nutrients such vitamins, minerals, fiber, fatty acids, and amino acids to boost the immune system, lower anxiety, and improve general health.
Regional Segment Analysis of the Global Softgel Capsule Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is anticipated to hold the largest share of the global softgel capsule market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the global softgel capsule market over the predicted timeframe. The softgel capsule market in North America has become the dominating regional market. This is because large capsule manufacturers are widely present in the region and have production facilities there, as well as the robust healthcare infrastructure and spending in nations like the United States. In order to create novel softgel dosage formulations that address various therapeutic uses, these companies have been making significant investments in research and development (R&D). The area thus benefits from early adoption of novel softgel products and has a high percentage of patent filings.
Because growth is slower in markets that are established due to legislation, population demographics, and market maturity than in other countries, ongoing innovation guarantees that end users of pharmaceuticals and nutraceuticals will always have a need. Additionally, the region uses trade agreements to dominate worldwide capsule exports. North America has been able to maintain its leadership in this industry due to general stability, chances for the introduction of innovative products, and a supportive regulatory environment.
Asia Pacific is expected to grow at the fastest CAGR growth of the global softgel capsule care market during the forecast period. The growth of this regional market is being driven by the expanding scientific basis and capabilities in Asia, the expansion of the pharmaceutical market in Asia and its production capabilities, and the substantial patient base in various Asia Pacific countries. Many international pharmaceutical manufacturers are building new manufacturing facilities or modernizing their current ones in the Asia Pacific region due to the region's massive growth potential and low cost of manufacturing.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global softgel capsule market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Sirio Pharma Company Limited.
- Catalent, Inc.
- EuroCaps Ltd.
- Guangdong Yichao Biological Co., Ltd.
- Aenova Group.
- CAPTEK Softgel International Inc.
- Thermo Fisher Scientific Inc.
- EyePoint Pharmaceuticals, Inc.
- Windzor Pharma Ltd.
- Lonza Capsules & Health Ingredients.
- ProCaps Laboratories, LLC.
- Soft Gel Technologies, Inc.
- Elnova Pharma.
- Captek Softgel International Inc.
- Hunan Er-Kang Pharmaceutical Co., Ltd
- Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In March 2023, Darlings Ingredients Inc. acquired Gelnex, which is a global producer of gelatin and collagen products. This acquisition would give the company the capacity to serve the growing needs of its collagen customers while continuing to serve the growing gelatin market.Thermo fisher launched Tumoroid Culture Medium to accelerate development of novel cancer therapies.
- In Jan 2023, Celix Pharma announced the launch of its new softgel capsules in the U.K. The new product Bexarotene 75mg soft-gel capsules is available in child- resistant, and HDPE bottle pack containing 100 capsules.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global softgel capsule market based on the below-mentioned segments:
Global Softgel Capsule Market, By Type
- Gelatin Capsules
- Non-Gelatin Softgel Capsules
Global Softgel Capsule Market, By Manufactures
- Pharmaceutical Companies
- Nutraceutical Companies
- Others
Global Softgel Capsule Market, By Application
- Pharmaceuticals
- Health Supplements
- Cosmetics & Personal Care
Global Softgel Capsule Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?